- Home
- RIVN vs BAX Comparison
RIVN vs BAX Comparison
Compare RIVN & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIVN
- BAX
- Stock Information
- Founded
- RIVN 2009
- BAX 1931
- Country
- RIVN United States
- BAX United States
- Employees
- RIVN N/A
- BAX N/A
- Industry
- RIVN Auto Manufacturing
- BAX Medical/Dental Instruments
- Sector
- RIVN Consumer Discretionary
- BAX Health Care
- Exchange
- RIVN Nasdaq
- BAX Nasdaq
- Market Cap
- RIVN 13.3B
- BAX 15.1B
- IPO Year
- RIVN 2021
- BAX N/A
- Fundamental
- Price
- RIVN $14.21
- BAX $30.97
- Analyst Decision
- RIVN Buy
- BAX Hold
- Analyst Count
- RIVN 22
- BAX 10
- Target Price
- RIVN $15.29
- BAX $40.90
- AVG Volume (30 Days)
- RIVN 36.8M
- BAX 4.8M
- Earning Date
- RIVN 02-20-2025
- BAX 02-06-2025
- Dividend Yield
- RIVN N/A
- BAX 3.37%
- EPS Growth
- RIVN N/A
- BAX N/A
- EPS
- RIVN N/A
- BAX 0.21
- Revenue
- RIVN $4,551,000,000.00
- BAX $15,062,000,000.00
- Revenue This Year
- RIVN $6.18
- BAX N/A
- Revenue Next Year
- RIVN $9.49
- BAX $6.57
- P/E Ratio
- RIVN N/A
- BAX $145.42
- Revenue Growth
- RIVN 20.33
- BAX 32.37
- 52 Week Low
- RIVN $8.26
- BAX $28.34
- 52 Week High
- RIVN $18.86
- BAX $44.01
- Technical
- Relative Strength Index (RSI)
- RIVN 53.39
- BAX 55.98
- Support Level
- RIVN $13.01
- BAX $30.12
- Resistance Level
- RIVN $16.65
- BAX $31.20
- Average True Range (ATR)
- RIVN 1.04
- BAX 0.71
- MACD
- RIVN -0.12
- BAX 0.35
- Stochastic Oscillator
- RIVN 37.28
- BAX 91.96
About RIVN Rivian Automotive Inc.
Rivian Automotive Inc designs, develops, and manufactures category-defining electric vehicles and accessories. In the consumer market, the company launched the R1 platform with the first generation of consumer vehicles: the R1T, a two-row, five-passenger pickup truck, and the R1S, a three-row, seven-passenger sport utility vehicle (SUV).
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter has signed an agreement to sell its kidney care tools by early 2025.